Table 1. Basic demographics of RA cases and healthy controls.
Association analysis | Clinical analysis | ||
---|---|---|---|
Diagnosis | RA n = 499 | HC n = 894 | RA n = 220 |
Age (years) | 57.3±12.1 | 41.2±12.1 | 58.1±11.5 |
Smoking (%) | 13.6 (N = 308) | 27.9 (N = 506) | 11.8 |
Disease duration (years) | 11.9±9.1 (N = 423) | 12.1±8.9 | |
RFa positive (%) | 72.6 (N = 351) | 75 | |
ACPAb positive (%) | 65.5 (N = 313) | 68.6 | |
CRPc (mg/l) | 11.7±15.2 (N = 398) | 13.5±16.3 | |
DAS28d | 4.6±1.4 | ||
Swollen joint count | 4.4±5.1 | ||
Tender joint count | 8.4±7 | ||
Morning stiffness (min) | 40.9±42.6 | ||
Glucocorticoids treated (%) | 59.1 | ||
Methotrexate treated (%) | 61.4 | ||
Biological treatment (%) | 9.1 | ||
NSAIDe treated (%) | 82.7 |
Data are expressed as mean ± SD.
aRF, Rheumatoid factor.
bACPA, Anti-citrullinated peptide antibodies.
cCRP, C-reactive protein.
dDAS28, disease activity score 28.
eNSAID, non-steroid anti-inflammatory drugs.